<SEC-DOCUMENT>0000921895-20-002327-index.html : 20200825 <SEC-HEADER>0000921895-20-002327.hdr.sgml : 20200825 <ACCEPTANCE-DATETIME>20200825172750 ACCESSION NUMBER: 0000921895-20-002327 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20200825 DATE AS OF CHANGE: 20200825 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Kymera Therapeutics, Inc. CENTRAL INDEX KEY: 0001815442 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812992166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-91636 FILM NUMBER: 201133292 BUSINESS ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-5314 MAIL ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BIOTECHNOLOGY VALUE FUND L P CENTRAL INDEX KEY: 0000918923 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] IRS NUMBER: 363924731 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 44 MONTGOMERY STREET STREET 2: 40TH FL CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 3125066500 MAIL ADDRESS: STREET 1: 44 MONTGOMERY STREET STREET 2: 40TH FL CITY: SAN FRANCISCO STATE: CA ZIP: 94104 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13D <SEQUENCE>1 <FILENAME>sc13d07422kymr_08252020.htm <DESCRIPTION>THE SCHEDULE 13D <TEXT> Document 1 - file: sc13d07422kymr_08252020.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>2 <FILENAME>ex992to13d07422kymr_082520.htm <DESCRIPTION>JOINT FILING AGREEMENT <TEXT> Document 2 - file: ex992to13d07422kymr_082520.htm
</DOCUMENT> </SEC-DOCUMENT>